Metabolism - Clinical and Experimental
Volume 45, Supplement 1 , Pages 4-7, August 1996

Regulation of somatostatin gene transcription by cyclic adenosine monophosphate

  • M. Montminy

      Affiliations

    • Corresponding Author InformationAddress reprint requests to M. Montminy, MD, PhD, The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, 10010 N Torrey Pines Rd, La Jolla, CA 92037.
    • Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA, USA
    • St Jude Children's Hospital, Memphis, TN, USA
    • Scripps Research Institute, La Jolla, CA, USA
    • VivoRx, Inc, Santa Monica, CA, USA
    • IDUN Pharmaceuticals, San Diego, CA, USA
  • ,
  • P. Brindle

      Affiliations

    • Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA, USA
    • St Jude Children's Hospital, Memphis, TN, USA
    • Scripps Research Institute, La Jolla, CA, USA
    • VivoRx, Inc, Santa Monica, CA, USA
    • IDUN Pharmaceuticals, San Diego, CA, USA
  • ,
  • J. Arias

      Affiliations

    • Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA, USA
    • St Jude Children's Hospital, Memphis, TN, USA
    • Scripps Research Institute, La Jolla, CA, USA
    • VivoRx, Inc, Santa Monica, CA, USA
    • IDUN Pharmaceuticals, San Diego, CA, USA
  • ,
  • K. Ferreri

      Affiliations

    • Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA, USA
    • St Jude Children's Hospital, Memphis, TN, USA
    • Scripps Research Institute, La Jolla, CA, USA
    • VivoRx, Inc, Santa Monica, CA, USA
    • IDUN Pharmaceuticals, San Diego, CA, USA
  • ,
  • R. Armstrong

      Affiliations

    • Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA, USA
    • St Jude Children's Hospital, Memphis, TN, USA
    • Scripps Research Institute, La Jolla, CA, USA
    • VivoRx, Inc, Santa Monica, CA, USA
    • IDUN Pharmaceuticals, San Diego, CA, USA

Abstract 

Cyclic adenosine monophosphate (cAMP) stimulates transcription of somatostatin and other target genes with burstattenuation kinetics. The kinetics of protein kinase (PK-A)—dependent cAMP response element binding protein (CREB) phosphorylation closely parallel the changes in transcription of cAMP-responsive genes by run-on assay. Nuclear translocation of PK-A, visualized by microinjection of fluorescently labeled PK-A holoenzyme, appears to represent the rate-limiting step in CREB phosphorylation and transcriptional activation. We and others have recently characterized a CREB-binding protein (CBP), which specifically recognizes sequences within the Ser133 phosphorylated form of CREB. CBP does not regulate the DNA binding, dimerization, or nuclear targeting properties of CREB, but binds selectively to the kinase-inducible 60 amino acid trans-activation domain (KID) of CREB, critical for PK-A—inducible transcription. We developed an antiserum directed against amino acid 634–648 within the CREB-binding domain of CBP. We detected a 265-kd polypeptide by Western blot as predicted from the cDNA, which coincided with the predominant phospho-CREB—binding activity in Hela nuclear extracts by “Far Western” blot assay. An identical phospho-CREB—binding activity was also found in NIH-3T3 cells. This phospho-CREB—binding protein appeared to be specific for Ser133-phosphorylated CREB, because no such band was detected with CREB labeled to the same specific activity at a nonregulatory phosphoacceptor site (Ser156) by casein kinase II (CKII). Following microinjection into nuclei of NIH-3T3 cells, a cAMP response element (CRE)-lacZ reporter was markedly induced by treatment with 8-Br cAMP plus isobutyl methyl xanthine (IBMX). Coinjection of CBP antiserum with the CRE-lacZ plasmid inhibited cAMP-dependent activity in a dose-dependent manner, but control immunoglobulin G (IgG) had no effect on this response. We can now begin reconstituting PK-A—dependent transcription in vitro, using well-characterized proteins such as CREB, TAF 110, and CBP. The assembly of such factors on cAMP-regulated promoters like somatostatin may enable responsiveness to a variety of hormonal stimuli that employ cAMP as their second messenger.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by NIH Grant No. GM37828 and the Foundation for Medical Research, Inc. M.M. is a Foundation for Medical Research investigator.

PII: S0026-0495(96)90068-2

Metabolism - Clinical and Experimental
Volume 45, Supplement 1 , Pages 4-7, August 1996